Hospital Mater Dei (BSP:MATD3) Beneish M-Score: -2.46 (As of Jun. 25, 2026)


BSP:MATD3 Hospital Mater Dei SA BSP:MATD3
85 GF Score
Price R$4.86
GF Value R$5.85
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is Hospital Mater Dei Beneish M-Score?

Hospital Mater Dei BSP:MATD3 +3.18% 85 Beneish M-Score is -2.46 as of Jun. 25, 2026. GuruFocus rates BSP:MATD3 with a GF Score™ of 85/100 and a GF Value™ of R$5.85 (Modestly Undervalued). The stock has 3 warning signs investors should review. Among 632 Healthcare Providers & Services companies, Hospital Mater Dei ranks worse than 61.08% on this metric.

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Good Sign:

Beneish M-Score -2.46 no higher than -1.78, which implies that the company is unlikely to be a manipulator.

The historical rank and industry rank for Hospital Mater Dei's Beneish M-Score or its related term are showing as below:

BSP:MATD3' s Beneish M-Score Range Over the Past 10 Years
Min: -3.36   Med: -2.2   Max: 0.18
Current: -2.46

During the past 9 years, the highest Beneish M-Score of Hospital Mater Dei was 0.18. The lowest was -3.36. And the median was -2.20.


Hospital Mater Dei Beneish M-Score Historical Data

* Premium members only.

The historical data trend for Hospital Mater Dei's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Hospital Mater Dei Beneish M-Score Chart

Hospital Mater Dei Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Beneish M-Score
Get a 7-Day Free Trial Premium Member Only -0.69 -2.20 -2.20 -3.29 -2.53

Hospital Mater Dei Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -3.36 -2.31 -2.38 -2.53 -2.46

BSP:MATD3 vs HCA, THC, DVA: Beneish M-Score Comparison

For the Medical Care Facilities subindustry, Hospital Mater Dei's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Hospital Mater Dei Beneish M-Score vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Hospital Mater Dei's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Hospital Mater Dei's Beneish M-Score falls into.


BSP:MATD3
85GF Score
Hospital Mater Dei SA BSP:MATD3
Beneish M-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Hospital Mater Dei Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Hospital Mater Dei for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 1.0593+0.528 * 0.9577+0.404 * 1.0054+0.892 * 1.0506+0.115 * 0.9487
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 0.9831+4.679 * -0.011514-0.327 * 0.998
=-2.46

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Mar26) TTM:Last Year (Mar25) TTM:
Total Receivables was R$812 Mil.
Revenue was 574.958 + 562.303 + 567.857 + 545.807 = R$2,251 Mil.
Gross Profit was 173.921 + 171.684 + 171.12 + 164.825 = R$682 Mil.
Total Current Assets was R$1,515 Mil.
Total Assets was R$4,335 Mil.
Property, Plant and Equipment(Net PPE) was R$1,473 Mil.
Depreciation, Depletion and Amortization(DDA) was R$113 Mil.
Selling, General, & Admin. Expense(SGA) was R$88 Mil.
Total Current Liabilities was R$521 Mil.
Long-Term Debt & Capital Lease Obligation was R$1,989 Mil.
Net Income was 32.566 + 37.48 + 26.865 + 26.235 = R$123 Mil.
Non Operating Income was 0 + 0 + 0 + 0 = R$0 Mil.
Cash Flow from Operations was 0.563 + 86.657 + 76.563 + 9.276 = R$173 Mil.
Total Receivables was R$730 Mil.
Revenue was 499.318 + 487.038 + 570.821 + 585.343 = R$2,143 Mil.
Gross Profit was 143.788 + 129.027 + 173.574 + 174.888 = R$621 Mil.
Total Current Assets was R$1,519 Mil.
Total Assets was R$4,377 Mil.
Property, Plant and Equipment(Net PPE) was R$1,506 Mil.
Depreciation, Depletion and Amortization(DDA) was R$109 Mil.
Selling, General, & Admin. Expense(SGA) was R$86 Mil.
Total Current Liabilities was R$515 Mil.
Long-Term Debt & Capital Lease Obligation was R$2,026 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(812.48 / 2250.925) / (730.076 / 2142.52)
=0.360954 / 0.340756
=1.0593

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(621.277 / 2142.52) / (681.55 / 2250.925)
=0.289975 / 0.302787
=0.9577

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (1515.405 + 1473.174) / 4334.97) / (1 - (1518.855 + 1506.294) / 4377.367)
=0.310588 / 0.308911
=1.0054

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=2250.925 / 2142.52
=1.0506

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(108.913 / (108.913 + 1506.294)) / (112.715 / (112.715 + 1473.174))
=0.06743 / 0.071074
=0.9487

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(88.42 / 2250.925) / (85.611 / 2142.52)
=0.039282 / 0.039958
=0.9831

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((1989.476 + 521.207) / 4334.97) / ((2025.841 + 514.518) / 4377.367)
=0.57917 / 0.58034
=0.998

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(123.146 - 0 - 173.059) / 4334.97
=-0.011514

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Hospital Mater Dei has a M-score of -2.46 suggests that the company is unlikely to be a manipulator.

Frequently Asked Questions Learn more about Beneish M-Score →
What does a Beneish M-Score of -2.46 mean?
Hospital Mater Dei (BSP:MATD3) has a Beneish M-Score of -2.46 as of Jun. 25, 2026. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on Hospital Mater Dei and its competitors. According to the industry distribution chart, Hospital Mater Dei ranks #386 out of 632 companies in the Healthcare Providers & Services industry, placing it in the top 61.1%.
Is Hospital Mater Dei's Beneish M-Score too high?
Hospital Mater Dei's current Beneish M-Score is -2.46. Based on the distribution chart, Hospital Mater Dei ranks #386 out of 632 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Hospital Mater Dei has a GF Score™ of 85/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Hospital Mater Dei's Beneish M-Score compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Hospital Mater Dei ranks #386 out of 632 companies for Beneish M-Score. This places Hospital Mater Dei in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beneish M-Score for a Healthcare Providers & Services company?
A good Beneish M-Score depends on the Healthcare Providers & Services industry context. However, Beneish M-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beneish M-Score mean?
A high Beneish M-Score can signal that a stock is expensive relative to its fundamentals. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on Hospital Mater Dei and its competitors. Hospital Mater Dei's current Beneish M-Score is -2.46. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hospital Mater Dei stock overvalued right now?
Based on GuruFocus' analysis, Hospital Mater Dei (BSP:MATD3) is currently considered Modestly Undervalued. The stock's GF Value™ is R$5.85, compared to a current price of R$4.86 — trading 16.9% below its estimated fair value. The current Beneish M-Score is -2.46. Hospital Mater Dei's overall GF Score™ is 85/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beneish M-Score calculated?
Beneish M-Score is calculated from a company's financial statements. For Hospital Mater Dei (BSP:MATD3), the current Beneish M-Score is -2.46 as of Jun. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Hospital Mater Dei (BSP:MATD3) Overvalued in 2026?

Based on GuruFocus' analysis, Hospital Mater Dei stock appears to be undervalued. The current stock price of R$4.86 is trading 16.9% below its estimated GF Value™ of R$5.85. GuruFocus considers Hospital Mater Dei to be Modestly Undervalued.

Key valuation signals for BSP:MATD3:

  • Beneish M-Score: -2.46
  • GF Value™: R$5.85 vs. price of R$4.86 (16.9% below fair value)
  • GF Score™: 85/100 with 3 warning signs

No single metric tells the full story. See the BSP:MATD3 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Hospital Mater Dei Business Description

Address Rua Mato Grosso, No. 1, 100, Bairro Santo Agostinho, Belo Horizonte, MG, BRA, 30.190-081
Hospital Mater Dei SA is an integrated healthcare ecosystem that provides hospital and oncological services. The company provides a wide range of healthcare services, including hospitalizations, surgeries, oncology treatments, medical appointments, and diagnostic exams.
85GF Score

Get the complete analysis for BSP:MATD3

Beneish M-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

R$4.86
Price
R$5.85
GF Value